(VREX) Varex Imaging - Ratings and Ratios
X-ray Tubes, Digital Detectors, X-ray Accelerators, Software
VREX EPS (Earnings per Share)
VREX Revenue
Description: VREX Varex Imaging
Varex Imaging Corporation is a leading global supplier of X-ray imaging components, catering to both medical and industrial applications. The companys diverse product portfolio includes X-ray tubes, digital detectors, and software solutions that enable advanced imaging capabilities. With a presence in multiple regions, including North America, Europe, and Asia, Varex Imaging is well-positioned to capitalize on the growing demand for medical imaging and industrial inspection technologies.
The companys Medical segment is a significant player in the healthcare industry, providing critical components for various diagnostic imaging modalities, such as CT, mammography, and oncology. Meanwhile, the Industrial segment serves the security and inspection markets, offering high-performance X-ray solutions for baggage screening, cargo inspection, and non-destructive testing. Varex Imagings products are sold through a mix of OEM partnerships, independent service providers, and direct sales to end-users, allowing the company to maintain a strong market presence.
From a technical analysis perspective, VREXs stock price has been trending downward, with the current price of $6.88 being at its 52-week low. The stock is below its 20-day, 50-day, and 200-day moving averages, indicating a bearish trend. The Average True Range (ATR) of 0.68, representing a 9.86% volatility, suggests that the stock is experiencing significant price fluctuations. Given the current technical setup, a potential trading strategy could be to wait for a breakout above the 20-day SMA of $7.98 or a reversal of the downtrend.
Fundamentally, Varex Imagings market capitalization stands at $359.12 million, with a forward P/E ratio of 41.49, indicating that the stock may be undervalued relative to its growth prospects. However, the companys negative Return on Equity (RoE) of -8.51% raises concerns about its profitability. To forecast the stocks future performance, we can analyze the trend in the companys revenue growth, profitability, and industry outlook. Assuming Varex Imaging can improve its profitability and capitalize on the growing demand for X-ray imaging technologies, a potential price target could be around $10-$12, representing a 45-75% upside from current levels.
Combining technical and fundamental insights, a potential trading strategy could be to accumulate VREX stock at current levels, with a stop-loss around $6.50, and a target price of $10-$12. However, its essential to closely monitor the companys future earnings reports, industry trends, and technical chart patterns to adjust the strategy accordingly. A thorough analysis of the companys financials, management team, and competitive positioning is also necessary to make an informed investment decision.
Additional Sources for VREX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
VREX Stock Overview
Market Cap in USD | 355m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2017-01-20 |
VREX Stock Ratings
Growth Rating | -48.7 |
Fundamental | -21.6 |
Dividend Rating | 0.0 |
Rel. Strength | -35.7 |
Analysts | 4.4 of 5 |
Fair Price Momentum | 6.73 USD |
Fair Price DCF | 5.53 USD |
VREX Dividends
Currently no dividends paidVREX Growth Ratios
Growth Correlation 3m | 30.1% |
Growth Correlation 12m | -52% |
Growth Correlation 5y | -52.6% |
CAGR 5y | -10.12% |
CAGR/Max DD 5y | -0.13 |
Sharpe Ratio 12m | -0.07 |
Alpha | -61.22 |
Beta | 1.725 |
Volatility | 44.77% |
Current Volume | 148.9k |
Average Volume 20d | 400k |
As of July 06, 2025, the stock is trading at USD 8.80 with a total of 148,900 shares traded.
Over the past week, the price has changed by +2.56%, over one month by +6.54%, over three months by +6.28% and over the past year by -38.68%.
Neither. Based on ValueRay´s Fundamental Analyses, Varex Imaging is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -21.64 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VREX is around 6.73 USD . This means that VREX is currently overvalued and has a potential downside of -23.52%.
Varex Imaging has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy VREX.
- Strong Buy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, VREX Varex Imaging will be worth about 8.1 in July 2026. The stock is currently trading at 8.80. This means that the stock has a potential downside of -8.3%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 16.6 | 88.6% |
Analysts Target Price | 16.6 | 88.6% |
ValueRay Target Price | 8.1 | -8.3% |